The University of Alberta Hospital is a research and teaching hospital in Edmonton, Alberta, Canada. The hospital is affiliated with the University of Alberta and run by Alberta Health Services, the health authority for Alberta.

There are 885 beds in University of Alberta Hospital, Pharmacy Services.

During the past decade, University of Alberta Hospital, Pharmacy Services conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Alberta Hospital, Pharmacy Services" are "Anemia, Sickle Cell" (1 trials), "Pain Crisis" (1 trials), "Sickle Cell Anemia" (1 trials), "Sickle Cell Disease" (1 trials) and "Sickle Cell Disorders" (1 trials). Many other conditions were trialed in "University of Alberta Hospital, Pharmacy Services" in a lesser frequency.

Most popular intervention types in "University of Alberta Hospital, Pharmacy Services" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rivipansel" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Alberta Hospital, Pharmacy Services" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Alberta Hospital, Pharmacy Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Alberta Hospital, Pharmacy Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alberta Hospital, Pharmacy Services, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".